Frontiers in Pharmacology (Jan 2022)

3-OBA Is Not an Antagonist of GPR81

Mohammad Ali Mohammad Nezhady,
Mohammad Ali Mohammad Nezhady,
Sylvain Chemtob,
Sylvain Chemtob

Affiliations

Mohammad Ali Mohammad Nezhady: Programmes en Biologie Moléculaire, Faculté de Médecine, Université de Montréal, Montreal, QC, Canada
Mohammad Ali Mohammad Nezhady: Centre de Recherche du CHU Sainte-Justine, Montreal, QC, Canada
Sylvain Chemtob: Programmes en Biologie Moléculaire, Faculté de Médecine, Université de Montréal, Montreal, QC, Canada
Sylvain Chemtob: Centre de Recherche du CHU Sainte-Justine, Montreal, QC, Canada

DOI: https://doi.org/10.3389/fphar.2021.803907
Journal volume & issue: Vol. 12

Abstract

No abstracts available.

Published in Frontiers in Pharmacology

ISSN: 1663-9812 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://journal.frontiersin.org/journals/pharmacology

About the journal